JLTS
2021-03-17
Nice
South African regulator approves Pfizer/BioNTech vaccine for emergency use<blockquote>南非监管机构批准辉瑞/BioNTech疫苗紧急使用</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":325438096,"tweetId":"325438096","gmtCreate":1615910987015,"gmtModify":1703495003449,"author":{"id":3575002815051060,"idStr":"3575002815051060","authorId":3575002815051060,"authorIdStr":"3575002815051060","name":"JLTS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice</p></body></html>","htmlText":"<html><head></head><body><p>Nice</p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/325438096","repostId":2119799199,"repostType":2,"repost":{"id":"2119799199","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615902519,"share":"https://www.laohu8.com/m/news/2119799199?lang=zh_CN&edition=full","pubTime":"2021-03-16 21:48","market":"us","language":"en","title":"South African regulator approves Pfizer/BioNTech vaccine for emergency use<blockquote>南非监管机构批准辉瑞/BioNTech疫苗紧急使用</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2119799199","media":"Reuters","summary":"JOHANNESBURG, March 16 (Reuters) - South Africa's drugs regulator SAHPRA said on Tuesday that it had","content":"<p><html><body>JOHANNESBURG, March 16 (Reuters) - South Africa's drugs regulator SAHPRA said on Tuesday that it had approved a \"section 21\" emergency use application for the COVID-19 vaccine developed by Pfizer and BioNTech .</p><p><blockquote><html><body>路透约翰内斯堡3月16日-南非药品监管机构SAHPRA周二表示，已批准辉瑞和BioNTech开发的COVID-19疫苗的“第21条”紧急使用申请。</body></html></blockquote></p><p> SAHPRA added in a statement that the approval was subject to further efficacy and safety surveillance of the vaccine in the country, including against the dominant local coronavirus variant.</p><p><blockquote>SAHPRA在一份声明中补充说，该批准取决于该疫苗在该国的进一步功效和安全性监测，包括针对当地主要冠状病毒变种的监测。</blockquote></p><p> (Reporting by Alexander Winning and Wendell Roelf)</p><p><blockquote>（亚历山大·温宁和温德尔·罗尔夫报道）</blockquote></p><p>((alexander.winning@tr.com; +27 10 346 1076))</p><p><blockquote>（（alexander.winning@tr.com；+27 10 346 107 6））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>South African regulator approves Pfizer/BioNTech vaccine for emergency use<blockquote>南非监管机构批准辉瑞/BioNTech疫苗紧急使用</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSouth African regulator approves Pfizer/BioNTech vaccine for emergency use<blockquote>南非监管机构批准辉瑞/BioNTech疫苗紧急使用</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-03-16 21:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>JOHANNESBURG, March 16 (Reuters) - South Africa's drugs regulator SAHPRA said on Tuesday that it had approved a \"section 21\" emergency use application for the COVID-19 vaccine developed by Pfizer and BioNTech .</p><p><blockquote><html><body>路透约翰内斯堡3月16日-南非药品监管机构SAHPRA周二表示，已批准辉瑞和BioNTech开发的COVID-19疫苗的“第21条”紧急使用申请。</body></html></blockquote></p><p> SAHPRA added in a statement that the approval was subject to further efficacy and safety surveillance of the vaccine in the country, including against the dominant local coronavirus variant.</p><p><blockquote>SAHPRA在一份声明中补充说，该批准取决于该疫苗在该国的进一步功效和安全性监测，包括针对当地主要冠状病毒变种的监测。</blockquote></p><p> (Reporting by Alexander Winning and Wendell Roelf)</p><p><blockquote>（亚历山大·温宁和温德尔·罗尔夫报道）</blockquote></p><p>((alexander.winning@tr.com; +27 10 346 1076))</p><p><blockquote>（（alexander.winning@tr.com；+27 10 346 107 6））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119799199","content_text":"JOHANNESBURG, March 16 (Reuters) - South Africa's drugs regulator SAHPRA said on Tuesday that it had approved a \"section 21\" emergency use application for the COVID-19 vaccine developed by Pfizer and BioNTech . SAHPRA added in a statement that the approval was subject to further efficacy and safety surveillance of the vaccine in the country, including against the dominant local coronavirus variant. (Reporting by Alexander Winning and Wendell Roelf)((alexander.winning@tr.com; +27 10 346 1076))","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":438,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/325438096"}
精彩评论